tiprankstipranks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market

Radiopharm Theranostics Limited (RAD) Financial Statements

2 Followers

Radiopharm Theranostics Limited Financial Overview

Radiopharm Theranostics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.133; its P/E ratio is -0.34; Radiopharm Theranostics Limited is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 26.98M
Total AssetsAU$ 83.38M
Total DebtAU$ 0.00
Net DebtAU$ -26.98M
Total LiabilitiesAU$ 20.42M
Stockholders EquityAU$ 62.96M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in AUD

Radiopharm Theranostics Limited Earnings and Revenue History

Radiopharm Theranostics Limited Debt to Assets

Radiopharm Theranostics Limited Cash Flow

Radiopharm Theranostics Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis